Akkan Mehmet Koray, Yalçın Ali Can, Tolga Zeydanlı, Öncü Fatih, Ilgıt Erhan Turgut, Önal Ahmet Baran, Zor Mustafa Hakan, Özer Abdullah
Gazi University Faculty of Medicine, Department of Radiology, Ankara, Turkey.
Konya City Hospital, Clinic of Radiology, Konya, Turkey.
Diagn Interv Radiol. 2025 Jan 1;31(1):39-44. doi: 10.4274/dir.2024.232524. Epub 2024 Jan 31.
The present study aims to (1) assess the technical success and limb salvage rates of endovascular therapy in patients with critical limb-threatening ischemia (CLTI) and infra-popliteal Trans-Atlantic Inter-Society Consensus (TASC) C/D lesions according to the updated 2015 TASC II classification and (2) to present our institutional experience.
A single-center retrospective study was conducted on patients with TASC C/D CLTI who underwent endovascular treatment between 2012 and 2017. The follow-up protocol consisted of Doppler ultrasound conduction every 3 months for the first year unless patients showed symptoms of CLTI. Patients with at least 1 year of follow-up data were included in the study, and if applicable their 3-year results were evaluated in terms of primary patency, absence of amputation, amputation-free survival, and overall survival.
A total of 248 patients and 287 limbs (238 TASC D lesions and 49 TASC C lesions) were treated via infra-popliteal percutaneous transluminal angioplasty. The overall technical success was 87%, the primary patency rate was 41.5% in the first year, and the freedom from amputation rates were 80.8% in 1 year and 67.7% in 3 years.
In patients with infra-popliteal arterial occlusive diseases, endovascular treatment methods demonstrate a high rate of technical success and favorable outcomes in limb preservation.
本研究旨在(1)根据2015年更新的TASC II分类,评估严重肢体缺血(CLTI)且腘下动脉病变为跨大西洋跨学会共识(TASC)C/D级患者的血管内治疗技术成功率和肢体挽救率,(2)介绍我们机构的经验。
对2012年至2017年间接受血管内治疗的TASC C/D级CLTI患者进行单中心回顾性研究。随访方案包括在第一年每3个月进行一次多普勒超声检查,除非患者出现CLTI症状。纳入至少有1年随访数据的患者,如有适用,对其3年结果进行主要通畅率、无截肢情况、无截肢生存率和总生存率方面的评估。
共有248例患者和287条肢体(238条TASC D级病变和49条TASC C级病变)接受了腘下经皮腔内血管成形术治疗。总体技术成功率为87%,第一年主要通畅率为41.5%,1年无截肢率为80.8%,3年为67.7%。
在腘下动脉闭塞性疾病患者中,血管内治疗方法显示出较高的技术成功率和良好的肢体保留效果。